Benaroya Research Institute’s second annual Immunology Symposium: New Horizons in Immunity and Disease will be taking place on Monday, April 28, 2025 from 8:30 a.m. – 4:30 p.m. at Town Hall Seattle, followed by a one hour reception (4:30-5:30) at Town Hall Seattle. We’re excited to bring together leading voices from the local and national immunology research community for a day of collaboration, learning, discussion and networking.
2024 was the inaugural year of the event and was a resounding success with a full house, exciting presentations, and impactful conversations. Mark your calendars and reserve the date, more information, including additional speakers and program overview, will be coming soon.
Registration has closed. Contact Marketing & Communications with any questions.
Program Agenda
Morning Agenda
8:30 a.m. - Doors Open: Coffee, Snacks, Vendor Booths
9:00 a.m. - Welcome: Jane Buckner, MD, BRI President
9:05 a.m. - Determinants of Response to Cancer Immunotherapy
Lawrence Fong, MD
Bezos Distinguished Scholar, Director, Immunotherapy Integrated Research Center
Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center
9:35 a.m. - Leveraging Computational Biology to Understand the Molecular Mechanisms Underpinning Immunologic Diseases
Matthew Altman, MD, MPhil
Affiliate Investigator, Center for Systems Immunology, Benaroya Research Institute
Associate Professor, Department of Medicine, University of Washington
10:05 a.m. - Short Talk: Interferons and Monocytes in Macrophage Activation Syndrome
Susan Canny, MD, PhD
Visiting Scientist, Center for Fundamental Immunology, Benaroya Research Institute
Rheumatology Attending, Seattle Children’s Hospital
Acting Assistant Professor, Department of Pediatrics, University of Washington
10:25 a.m. - Break, Visit Vendor Booths
10:50 a.m. - Creating a Small and Large Intestine on a Microscale to Model Normal and Disease Physiology
Nancy Allbritton, MD, PhD
Frank & Julie Jungers Dean College of Engineering, Professor of Bioengineering, University of Washington
11:20 a.m. - Are Integrins Integral for Intestinal Immunity?
Adam Lacy-Hulbert, PhD
Member and Director, Center for Systems Immunology, Benaroya Research Institute
Affiliate Professor, Department of Immunology, University of Washington
11:50 a.m. - Short Talk: Tissue Signals Regulating Commensal-Specific CD8⍺ꞵ+ T Cells in the Intestines
Tayla Olsen
Graduate Student, Center for Fundamental Immunology, Benaroya Research Institute
Graduate Student, Molecular and Cellular Biology Program, University of Washington
12:10 p.m. - Lunch
Afternoon Agenda
1:10 p.m. - KEYNOTE: Unraveling the Core Architecture of the CD4+ T Cell Response
Marc Jenkins, PhD
Regents Professor, Department of Microbiology and Immunology, University of Minnesota Medical School
2:10 p.m. - Paths to T Cell Exhaustion in T1D
Alice Long, PhD
Associate Member, Center for Translational Immunology, Benaroya Research Institute
2:40 p.m. - Short Talk: Chromatin Repression and Metabolic Rewiring in RRMS Flare: A Multi-Omic View
Arpit Mishra, PhD
Staff Scientist, Center for Translational Immunology, Benaroya Research Institute
3:00 p.m. - Break, Visit Vendor Booths
3:25 p.m. - Understanding CD4+ T cell Heterogeneity in the Tissues
Marion Pepper, PhD
Professor and Chair, Department of Immunology, University of Washington
3:55 p.m. - Temporal Stability and Clonal Diversity of CMV-Specific T Cells During Latent Infection
Dan Campbell, PhD
Member and Director, Center for Fundamental Immunology, Benaroya Research Institute
Affiliate Professor, Department of Immunology, University of Washington
4:30 p.m. - Symposium Ends; One-Hour Reception Begins
2025 BRI Immunology Symposium Speakers
The speakers at the 2025 event include our keynote speaker, Marc Jenkins, PhD, of the University of Minnesota. In addition, we are joined by additional speakers, Marion Pepper, PhD, Professor and Chair, Dept of Immunology, University of Washington, Nancy Allbritton, MD, PhD, Frank & Julie Jungers Dean, College of Engineering, Professor of Bioengineering, University of Washington, and Lawrence Fong, MD, Bezos Distinguished Scholar, Director, Immunotherapy Integrated Research Center, Professor, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center.
More speakers will be added as soon as possible. Please contact communications@benaroyaresearch.org if you have any questions.
Booth Sponsors
Media Sponsor
News
CD4 Memory T Cells may be Responsible for High Efficacy of Shingles Vaccine
Read More
Benaroya Research Institute Awarded $11 Million Across Eight Grants in Second Half of 2024 to Predict, Prevent, Reverse and Cure Immune System Diseases
Read More
Milk-Specific T Cell Suggests that Eosinophilic Esophagitis (EoE) is a Food Allergy
Read More
Featured Publications
A molecular basis for milk allergen immune recognition in eosinophilic esophagitis.
J Allergy Clin Immunol
A coding single nucleotide polymorphism in the interleukin-6 receptor enhances IL-6 signalling in CD4 T cells and predicts treatment response to tocilizumab in giant cell arteritis.
Ann Rheum Dis
A systematic review of machine learning-based prognostic models for acute pancreatitis: Towards improving methods and reporting quality.
PLoS Med
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
Diabetologia
Defining a novel DYRK1A-gp130/IL-6R-pSTAT axis that regulates Th17 differentiation.
Immunohorizons
